| Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676) |
|---|
| 05/25/2001 | WO2000077027A3 Serine protease inhibitors |
| 05/25/2001 | WO2000039081A3 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds |
| 05/23/2001 | EP1101763A2 Method for preparing sodium-hydrogen exchanger type 1 inhibitor |
| 05/23/2001 | EP1101758A1 Fused-heterocycle dicarboxylic diamide derivatives or salts thereof, herbicides and usage thereof |
| 05/23/2001 | EP1100805A1 Medicine nitrate salts |
| 05/23/2001 | EP1100795A1 Disubstituted bicyclic heterocycles having, in particular, a thrombin inhibitive effect |
| 05/23/2001 | EP1100519A1 Multibinding agents that modulate nmda receptors |
| 05/23/2001 | EP1100504A2 Pharmaceutical compositions and their uses for treatment of demyelinating disorders |
| 05/23/2001 | EP1100503A2 Non-imidazole alkylamines as histamine h 3?-receptor ligands and their therapeutic applications |
| 05/23/2001 | EP1100485A1 Substituted anilide compounds and methods |
| 05/23/2001 | EP0689536B1 Naphthalene derivatives |
| 05/23/2001 | DE19950404A1 Mittel und Verfahren zur Färbung von Fasern Agents and methods for coloring fibers |
| 05/23/2001 | CN1296478A Histamine H3 receptor ligands |
| 05/23/2001 | CN1066133C Substituted (hetero) aryl compounds, process for preparation, agents containing them, and their use |
| 05/22/2001 | US6235787 Antiinflammatory agents; rheumatic diseases; bone disorders; skin disorders; multiple sclerosis |
| 05/22/2001 | US6235778 Anticoagulants |
| 05/22/2001 | US6235753 Tumor necrosis factor; autoimmune diseases; antiallergens |
| 05/22/2001 | US6235736 3-anilino-2-cycloalkenone derivatives |
| 05/22/2001 | US6235732 Neurokinin antagonists |
| 05/22/2001 | US6235686 N-heterocycle polymers as oil additive |
| 05/22/2001 | US6233841 Dehydration plant |
| 05/17/2001 | WO2001034570A1 Nitrogenous heterocycle derivatives |
| 05/17/2001 | WO2001034557A1 Process for the production of optically active cyclic enaminone derivatives |
| 05/17/2001 | DE19954816A1 New 4-amino-quinazoline or quinoline derivatives, are tyrosine kinase-mediated signal transduction inhibitors useful e.g. for treating tumors, polyps or respiratory or gastrointestinal diseases |
| 05/17/2001 | CA2390921A1 Process for the production of optically active cyclic enaminone derivative |
| 05/16/2001 | EP1099701A1 7-[(4'-Trifluoromethyl-biphenyl-2-carbonyl)amino]-quinoline-3-carboxylic acid amides, and methods of inhibiting the secretion of apolipoprotein B |
| 05/16/2001 | EP1099694A1 Process for the preparation of quinoline derivative and intermediate therefor |
| 05/16/2001 | EP1099692A1 N,n-substituted cyclic amine derivatives |
| 05/16/2001 | EP1098864A1 Method for hydrogenating unsaturated heterocyclic compounds |
| 05/16/2001 | EP1098662A2 Coadministration of acat and mmp inhibitors for the treatment of atherosclerotic lesions |
| 05/16/2001 | CN1295562A Biocidal benzylbiphenyl derivatives |
| 05/16/2001 | CN1295479A Beta 2-adrenergic receptor agonist |
| 05/16/2001 | CN1295070A Process for prep. of 1-type sodium-hydrogen exchange agent inhibitor |
| 05/15/2001 | US6232342 Protease inhibitors |
| 05/15/2001 | US6232321 Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses |
| 05/15/2001 | US6232313 Pyridazino quinoline compounds |
| 05/15/2001 | CA2196539C Process for making quinolonyl lactam antimicrobials and novel intermediate compounds |
| 05/10/2001 | WO2001032649A1 Arylalkane, arylalkene and aryl azaalkane, medicaments containing said compounds and method for the production thereof |
| 05/10/2001 | WO2001032646A2 Sulfonamide derivatives |
| 05/10/2001 | WO2001032636A1 Benzoylcyclohexandione and benzoylpyrazols, method for the production and use thereof as herbicides and plant growth regulators |
| 05/10/2001 | WO2001032611A1 N-guanidinoalkylamides, their preparation, their use, and pharmaceutical preparations comprising them |
| 05/10/2001 | WO2001032604A1 Activators of soluble guanylate cyclase |
| 05/10/2001 | WO2001032602A1 Diaryl-enynes |
| 05/10/2001 | WO2001032171A1 5-benzyl-octahydroindole and 6-benzyl-decahydroquinoline nmda/nr2b antagonists |
| 05/10/2001 | DE19953136A1 Benzoylcyclohexandione und Benzoylpyrazole, Verfahren zu ihrer Herstellung und ihre Verwendung als Herbizide und Pflanzenwachstumsregulatoren Benzoylcyclohexanediones and benzoylpyrazoles, processes for their preparation and their use as herbicides and plant growth regulators |
| 05/10/2001 | CA2397361A1 Benzoylcyclohexanediones and benzoylpyrazoles, their preparation and their use as herbicides and plant growth regulators |
| 05/10/2001 | CA2389773A1 Activators of soluble guanylate cyclase |
| 05/10/2001 | CA2389184A1 5-benzyl-octahydroindole and 6-benzyl-decahydroquinoline nmda/nr2b antagonists |
| 05/10/2001 | CA2387660A1 Diaryl-enynes as glycine transport inhibitors |
| 05/10/2001 | CA2387613A1 Arylalkanes, arylalkenes and aryl-azaalkanes, pharmaceutical compositions containing these compounds and processes for preparing them |
| 05/09/2001 | EP1097719A1 NEP inhibitors for the treatment of female sexual dysfunction |
| 05/09/2001 | EP1097718A1 NPY antagonists for the treatment of female sexual dysfunction |
| 05/09/2001 | EP1097707A1 Treatment of female sexual dysfunction |
| 05/09/2001 | EP1097706A1 Phosphodiesterase inhibitors for the treatment of female sexual dysfunction |
| 05/09/2001 | EP1097139A1 Quinoline derivatives |
| 05/09/2001 | EP1097138A1 Pharmaceutical compositions comprising 2-quinolones |
| 05/09/2001 | EP0813519B1 Sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors |
| 05/09/2001 | CN1294592A Process for preparing (-) pyridobenzoxazine carboxylic acid derivatives |
| 05/09/2001 | CN1065529C 4-quinolinone derivative or salt thereof |
| 05/08/2001 | US6229017 Process for preparing quinolone- and naphthyridone- carboxylic acids and esters thereof |
| 05/08/2001 | US6229011 N-aroylphenylalanine derivative VCAM-1 inhibitors |
| 05/08/2001 | US6228869 Ortho-sulfonamido bicyclic hydroxamic acids as matrix metalloproteinase and TACE inhibitors |
| 05/08/2001 | US6228848 3-(1-propen-3-oxo)-5,6-dihydronaphthalene derivatives; side effect reduction |
| 05/08/2001 | CA2324484A1 Compounds for the treatment of female sexual dysfunction |
| 05/08/2001 | CA2323464A1 Compounds for the treatment of female sexual dysfunction |
| 05/08/2001 | CA2323191A1 Compounds for the treatment of female sexual dysfunction |
| 05/08/2001 | CA2323183A1 Compounds for the treatment of female sexual dysfunction |
| 05/08/2001 | CA2024865C Preparation of 3-methylquinoline-8-carboxylic acid |
| 05/03/2001 | WO2001030758A1 Drugs for the treatment of malignant tumours |
| 05/03/2001 | WO2001030749A1 Novel compounds |
| 05/03/2001 | WO2001030734A1 Novel hydronaphtalene compounds, prepared by a rhodium catalyzed ring opening reaction in the presence of phosphine ligand |
| 05/03/2001 | WO2001030333A2 Tissue factor antagonists and methods of use thereof |
| 05/03/2001 | WO2001012607A3 Pharmaceutical compositions comprising 4-quinolones for treating cancers |
| 05/03/2001 | CA2387857A1 Tissue factor antagonists and methods of use thereof |
| 05/02/2001 | EP1095933A1 Novel N-guanidinoalkylamides, their preparation, their use, and pharmaceutical preparations comprising them |
| 05/02/2001 | EP1095021A1 Quinoline derivatives |
| 05/02/2001 | EP1095016A1 Sulfur substituted sulfonylaminocarboxylic acid n-arylamides, their preparation, their use and pharmaceutical preparations comprising them |
| 05/02/2001 | EP1095015A2 Sulfonylamino carboxylic acid n-arylamides as guanylate cyclase activators |
| 05/02/2001 | EP1094826A1 Novel therapeutic agents that modulate alpha-1a adrenergic receptors |
| 05/02/2001 | EP1094816A1 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists |
| 05/02/2001 | EP0984959A4 Aromatic sulfonyl alpha-hydroxy hydroxamic acid compounds |
| 05/02/2001 | EP0983257A4 Aromatic sulfonyl alpha-cycloamino hydroxamic acid compounds |
| 05/02/2001 | EP0973392A4 Sulfonyl divalent aryl or heteroaryl hydroxamic acid compounds |
| 05/02/2001 | CN1293669A Benzylpiperazingl-and benzylipeeridinyl ethanone derivatives, their preparation method and their use as dopamine D receptor antagonists |
| 05/01/2001 | US6225331 For therapy and prophylaxis nasal congestion, otitis media, and sinusitis, treating cough, chronic obstructive pulmonary disease (copd) and/or asthma, benign prostatic hypertrophy, cardiovascular disorders, glaucoma, hyperemia, conjunctivitis |
| 05/01/2001 | US6225312 Piperazine and piperidine compounds |
| 05/01/2001 | CA2197178C Bicyclolactam compounds, use of the same and intermediate in the production of the same |
| 04/29/2001 | CA2324640A1 Method for preparing sodium-hydrogen exchanger type 1 inhibitor |
| 04/26/2001 | WO2001029026A1 Phenyl- and pyridyl-tetrahydro-pyridines having tnf inhibiting activity |
| 04/26/2001 | WO2001028507A1 Agent and method for colouring fibres |
| 04/26/2001 | WO2000075121A3 Process for preparing 10,11-methanobenzosuberane derivatives |
| 04/26/2001 | WO2000055125A3 N-cyanomethyl amides as protease inhibitors |
| 04/25/2001 | CN1292791A Herbicidally active 3-hydroxy-4-aryl-5-oxopyrazoline derivatives |
| 04/24/2001 | US6222036 Reacting 2-thio-4-dimethyoxymethyl-pyrimidine with acetic acid and catalytic amount of concetrated sulfuric acid to produce 2-thiopyrimidine aldehyde |
| 04/24/2001 | US6221881 Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses |
| 04/19/2001 | WO1998008546A8 Therapeutic combinations of rar antagonists and rxr agonists and use thereof |
| 04/19/2001 | US20010000345 Compounds such as (4,7-dimethylbenzimidazol-5-yl)guanidine; treating nasal congestion, otitis media, asthma, pain, migraine, gastrointestinal disorder, ulcer |
| 04/18/2001 | EP1091955A1 Quinolones as serine protease inhibitors |
| 04/18/2001 | EP1091939A1 Substituted quinolin-2(1h)-ones useful as hiv reverse transcriptase inhibitors |
| 04/18/2001 | EP0968250B1 Soluble chromophores having improved solubilising groups |